These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 32717284)
1. Insight into the in vivo translocation of oral liposomes by fluorescence resonance energy transfer effect. Liu W; Li D; Dong Z; Liu K; He H; Lu Y; Wu W; Li Q; Gan L; Qi J Int J Pharm; 2020 Sep; 587():119682. PubMed ID: 32717284 [TBL] [Abstract][Full Text] [Related]
2. Loss of integrity of doxorubicin liposomes during transcellular transportation evidenced by fluorescence resonance energy transfer effect. Li D; Zhuang J; Yang Y; Wang D; Yang J; He H; Fan W; Banerjee A; Lu Y; Wu W; Gan L; Qi J Colloids Surf B Biointerfaces; 2018 Nov; 171():224-232. PubMed ID: 30036789 [TBL] [Abstract][Full Text] [Related]
3. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery. Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging. Tahara K; Nishio M; Takeuchi H Drug Dev Ind Pharm; 2018 Apr; 44(4):608-614. PubMed ID: 29166794 [TBL] [Abstract][Full Text] [Related]
6. Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial Barriers. Wang A; Yang T; Fan W; Yang Y; Zhu Q; Guo S; Zhu C; Yuan Y; Zhang T; Gan Y Adv Healthc Mater; 2019 Jun; 8(12):e1801123. PubMed ID: 30485708 [TBL] [Abstract][Full Text] [Related]
7. Influence of Particle Geometry on Gastrointestinal Transit and Absorption following Oral Administration. Li D; Zhuang J; He H; Jiang S; Banerjee A; Lu Y; Wu W; Mitragotri S; Gan L; Qi J ACS Appl Mater Interfaces; 2017 Dec; 9(49):42492-42502. PubMed ID: 29148702 [TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880 [TBL] [Abstract][Full Text] [Related]
9. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Han HK; Shin HJ; Ha DH Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. Sun W; Zou W; Huang G; Li A; Zhang N J Drug Target; 2008 Jun; 16(5):357-65. PubMed ID: 18569280 [TBL] [Abstract][Full Text] [Related]
11. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754 [TBL] [Abstract][Full Text] [Related]
12. Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes). Jain S; Patil SR; Swarnakar NK; Agrawal AK Mol Pharm; 2012 Sep; 9(9):2626-35. PubMed ID: 22871060 [TBL] [Abstract][Full Text] [Related]
13. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310 [TBL] [Abstract][Full Text] [Related]
14. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge. Velpula A; Jukanti R; Janga KY; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR Drug Dev Ind Pharm; 2013 Dec; 39(12):1895-906. PubMed ID: 22458264 [TBL] [Abstract][Full Text] [Related]
15. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
16. Effect of liposomes on the absorption of water-soluble active pharmaceutical ingredients via oral administration. Yang Z; Lu A; Wong BC; Chen X; Bian Z; Zhao Z; Huang W; Zhang G; Chen H; Xu M Curr Pharm Des; 2013; 19(37):6647-54. PubMed ID: 23621538 [TBL] [Abstract][Full Text] [Related]
17. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery. Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398 [TBL] [Abstract][Full Text] [Related]
18. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug. Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915 [TBL] [Abstract][Full Text] [Related]
19. Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome. Yamazoe E; Fang JY; Tahara K Int J Pharm; 2021 Jan; 593():120148. PubMed ID: 33290871 [TBL] [Abstract][Full Text] [Related]
20. Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers. Ding R; Li Y; Zheng W; Sun Y; Zhao Z; Zhang H; Yuan R; Wang A; Sun K; Wang H; Shi Y AAPS J; 2024 Sep; 26(5):102. PubMed ID: 39266802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]